Works matching DE "DEOXYCYTIDINE"

Results: 549

Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO study.

Published in:

Oncologist, 2025, v. 30, n. 6, p. 1, doi. 10.1093/oncolo/oyaf080

By:

Blanc, Jean-Frédéric;
Bouattour, Mohamed;
Gauthier, Ludovic;
Deshayes, Emmanuel;
Guillemard, Sophie;
Touchefeu, Yann;
Portales, Fabienne;
Borg, Christophe;
Harguem, Lobna;
Guimbaud, Rosine;
Mineur, Laurent;
Ychou, Marc;
Mazard, Thibault;
Assenat, Eric

Publication type:

Article

Preclinical studies of 5-fluoro-2′-deoxycytidine and tetrahydrouridine in pediatric brain tumors.

Published in:

Journal of Neuro-Oncology, 2016, v. 126, n. 2, p. 225, doi. 10.1007/s11060-015-1965-0

By:

Morfouace, Marie;
Nimmervoll, Birgit;
Boulos, Nidal;
Patel, Yogesh;
Shelat, Anang;
Freeman, Burgess;
Robinson, Giles;
Wright, Karen;
Gajjar, Amar;
Stewart, Clinton;
Gilbertson, Richard;
Roussel, Martine

Publication type:

Article

Microwave ablation plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer: a multicenter, randomized, controlled, phase III clinical trial.

Published in:

2020

By:

Wei, Zhigang;
Yang, Xia;
Ye, Xin;
Feng, Qingliang;
Xu, Yanjun;
Zhang, Licheng;
Sun, Wenqiao;
Dong, Yuting;
Meng, Qi;
Li, Tao;
Wang, Chuntang;
Li, Guangxu;
Zhang, Kaixian;
Li, Peishun;
Bi, Jingwang;
Xue, Guoliang;
Sun, Yahong;
Sheng, Lijun;
Liu, Bin;
Yu, Guohua

Publication type:

journal article

Dynamic Behavior and Ligand Binding Properties of the Wild Type Deoxycytidine Kinase and its Characterized Gemcitabine-Resistant Variant: A Bioinformatics and Computational Study.

Published in:

Journal of Computational Biophysics & Chemistry, 2024, v. 23, n. 1, p. 25, doi. 10.1142/S2737416523500485

By:

Rahmati, Yasmin;
Khalifeh, Khosrow;
Heshmati, Emran

Publication type:

Article

Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 245, doi. 10.1634/theoncologist.2016-0265

By:

Vahdat, Linda T.;
Layman, Rachel;
Yardley, Denise A.;
Gradishar, William;
Salkeni, Mohamad A.;
Joy, Anil Abraham;
Garcia, Agustin A.;
Ward, Patrick;
Khatcheressian, James;
Sparano, Joseph;
Rodriguez, Gladys;
Tang, Shande;
Gao, Ling;
Dalal, Rita P.;
Kauh, John;
Miller, Kathy

Publication type:

Article

A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First-Line Treatment of Pancreatic Adenocarcinoma.

Published in:

Oncologist, 2017, v. 22, n. 3, p. 241, doi. 10.1634/theoncologist.2017-0024

By:

Benson, Al B.;
Wainberg, Zev A.;
Hecht, J. Randolph;
Vyushkov, Dmitry;
Dong, Hua;
Bendell, Johanna;
Kudrik, Fred

Publication type:

Article

Targeting host deoxycytidine kinase mitigates Staphylococcus aureus abscess formation.

Published in:

eLife, 2024, p. 1, doi. 10.7554/eLife.91157

By:

Winstel, Volker;
Abt, Evan R.;
Le, Thuc M.;
Radu, Caius G.

Publication type:

Article

Should Patients Be Required to Undergo Standard Chemotherapy Before Being Eligible for Novel Phase I Immunotherapy Clinical Trials?

Published in:

2017

By:

Wilfond, Benjamin S.;
Morales, Christian;
Taylor, Holly A.

Publication type:

Case Study

Epigenome-wide association study identifies Behçet's disease-associated methylation loci in Han Chinese.

Published in:

Rheumatology, 2019, v. 58, n. 9, p. 1574, doi. 10.1093/rheumatology/kez043

By:

Yu, Hongsong;
Du, Liping;
Yi, Shenglan;
Wang, Qingfeng;
Zhu, Yunyun;
Qiu, Yiguo;
Jiang, Yan;
Li, Minghui;
Wang, Detao;
Wang, Qing;
Yuan, Gangxiang;
Cao, Qingfeng;
Kijlstra, Aize;
Yang, Peizeng

Publication type:

Article

5-Aza-2'-deoxycytidine acts as a modulator of chondrocyte hypertrophy and maturation in chick caudal region chondrocytes in culture.

Published in:

Anatomy & Cell Biology, 2016, v. 49, n. 2, p. 107, doi. 10.5115/acb.2016.49.2.107

By:

Haq, Samina Hyder

Publication type:

Article

Aberrant promoter 2 methylation-mediated downregulation of protein tyrosine phosphatase, non-receptor type 6, is associated with progression of esophageal squamous cell carcinoma.

Published in:

Molecular Medicine Reports, 2019, v. 19, n. 4, p. 3273

By:

Liu, Lei;
Zhang, Shaowei;
Liu, Xinbo;
Liu, Junfeng

Publication type:

Article

5-aza-2'-deoxycytidine promotes migration of acute monocytic leukemia cells via activation of CCL2-CCR2-ERK signaling pathway.

Published in:

Molecular Medicine Reports, 2017, v. 16, n. 2, p. 1417, doi. 10.3892/mmr.2017.6737

By:

XIA XIAO;
QIAN XU;
YAN SUN;
ZIWEI LU;
RUI LI;
XINXIN WANG;
XIN JIANG;
GUIRONG ZHANG;
YECHEN XIAO

Publication type:

Article

Standardization of the methylation-specific PCR method for analyzing BRCA1 and ER methylation.

Published in:

Molecular Medicine Reports, 2014, v. 9, n. 5, p. 1844, doi. 10.3892/mmr.2014.1990

By:

VO THI THUONG LAN;
NGO THI HA;
NGUYEN QUYNH UYEN;
NGUYEN THI DUONG;
NGUYEN THI THU HUONG1;
TA BICH THUAN;
PHAM ANH THUY DUONG;
TA VAN TO

Publication type:

Article

DNA demethylation by 5-aza-2'-deoxycytidine is imprinted, targeted to euchromatin, and has limited transcriptional consequences.

Published in:

Epigenetics & Chromatin, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13072-015-0004-x

By:

Ramos, María-Paz;
Neil Ari Wijetunga;
McLellan, Andrew S.;
Masako Suzuki;
Greally, John M.

Publication type:

Article

Aberrant promoter methylation of Dab2 gene in myelodysplastic syndrome.

Published in:

European Journal of Haematology, 2012, v. 89, n. 6, p. 469, doi. 10.1111/ejh.12014

By:

Yang, Yujuan;
Zhang, Qingxia;
Xu, Feng;
Chang, Chunkang;
Li, Xiao

Publication type:

Article

Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF.

Published in:

Journal of Hematology & Oncology, 2012, v. 5, n. 1, p. 58, doi. 10.1186/1756-8722-5-58

By:

Roy, Sanchita;
Levi, Edi;
Majumdar, Adhip P. N.;
Sarkar, Fazlul H.

Publication type:

Article

CRABP-II methylation: A critical determinant of retinoic acid resistance of medulloblastoma cells

Published in:

Molecular Oncology, 2012, v. 6, n. 1, p. 48, doi. 10.1016/j.molonc.2011.11.004

By:

Fu, Yuan-Shan;
Wang, Qian;
Ma, Jing-Xin;
Yang, Xiang-Hong;
Wu, Mo-Li;
Zhang, Kai-Li;
Kong, Qing-You;
Chen, Xiao-Yan;
Sun, Yuan;
Chen, Nan-Nan;
Shu, Xiao-Hong;
Li, Hong;
Liu, Jia

Publication type:

Article

Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective study.

Published in:

2017

By:

Cihoric, Nikola;
Tsikkinis, Alexandros;
Badra, Eugenia Vlaskou;
Glatzer, Markus;
Novak, Urban;
Scherz, Amina;
Shelan, Mohamed;
Soldatovic, Ivan;
Yojena, Chittazhathu Kurian Kuruvilla;
Aebersold, Daniel M.;
Lössl, Kristina;
Vlaskou Badra, Eugenia

Publication type:

journal article

"HEATPAC" - a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer.

Published in:

2017

By:

Datta, Niloy Ranjan;
Pestalozzi, Bernhard;
Clavien, Pierre-Alain;
Siebenhüner, Alexander;
Puric, Emsad;
Khan, Shaka;
Mamot, Christoph;
Riesterer, Oliver;
Knuchel, Jürg;
Reiner, Cäcilia Sophie;
Bodis, Stephan;
members of the HEATPAC Trial Group

Publication type:

journal article

Quantification of renal function following stereotactic body radiotherapy for pancreatic cancer: secondary dosimetric analysis of a prospective clinical trial.

Published in:

2017

By:

Verma, Vivek;
Bhirud, Abhijeet R.;
Denniston, Kyle A.;
Bennion, Nathan R.;
Chi Lin;
Lin, Chi

Publication type:

journal article

Considerable interobserver variation in delineation of pancreatic cancer on 3DCT and 4DCT: a multi-institutional study.

Published in:

2017

By:

Versteijne, Eva;
Gurney-Champion, Oliver J.;
van der Horst, Astrid;
Lens, Eelco;
Kolff, M. Willemijn;
Buijsen, Jeroen;
Ebrahimi, Gati;
Neelis, Karen J.;
Rasch, Coen R. N.;
Stoker, Jaap;
van Herk, Marcel;
Bel, Arjan;
van Tienhoven, Geertjan

Publication type:

journal article

Antiproliferative Activity of the Chinese Medicinal Compound, Delisheng, Compared With Rg3 and Gemcitabine in HepG2 Cells.

Published in:

Indian Journal of Pharmaceutical Sciences, 2013, v. 75, n. 5, p. 578

By:

S. H. WANG;
Y. C. WANG;
Y. L. NIE;
Y. N. HAI;
H. F. SUN;
Z. L. YUAN;
K. J. NAN

Publication type:

Article

The Effects of 5-Aza-2'-deoxycytidine on Total Lipid and Fatty Acid Composition of Apanteles galleriae Wilkinson (Hymenoptera: Braconidae) and on Its Parasitized Host.

Published in:

Journal of the Entomological Research Society, 2017, v. 19, n. 1, p. 105

By:

SAK, Olga

Publication type:

Article

Phase 1 study of the ATR inhibitor berzosertib (formerly M6620, VX-970) combined with gemcitabine ± cisplatin in patients with advanced solid tumours.

Published in:

2021

By:

Middleton, Mark R.;
Dean, Emma;
Evans, Thomas R. J.;
Shapiro, Geoffrey I.;
Pollard, John;
Hendriks, Bart S.;
Falk, Martin;
Diaz-Padilla, Ivan;
Plummer, Ruth

Publication type:

journal article

Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer.

Published in:

2021

By:

Willenbrock, Frances;
Cox, Catrin M.;
Parkes, Eileen E.;
Wilhelm-Benartzi, Charlotte S.;
Abraham, Aswin G.;
Owens, Robert;
Sabbagh, Ahmad;
Jones, Christopher M.;
Hughes, Daniel L. I.;
Maughan, Tim;
Hurt, Christopher N.;
O'Neill, Eric E.;
Mukherjee, Somnath

Publication type:

journal article

Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer - translational results from the AIO-PK0104 Phase 3 study.

Published in:

2020

By:

Guenther, Michael;
Haas, Michael;
Heinemann, Volker;
Kruger, Stephan;
Westphalen, Christoph Benedikt;
von Bergwelt-Baildon, Michael;
Mayerle, Julia;
Werner, Jens;
Kirchner, Thomas;
Boeck, Stefan;
Ormanns, Steffen

Publication type:

journal article

Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer models.

Published in:

2020

By:

Dunlop, Charles R.;
Wallez, Yann;
Johnson, Timothy Isaac;
Bernaldo de Quirós Fernández, Sandra;
Durant, Stephen T.;
Cadogan, Elaine B.;
Lau, Alan;
Richards, Frances M.;
Jodrell, Duncan I.

Publication type:

journal article

Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis.

Published in:

2020

By:

Yoo, Changhoon;
Lee, Sang Soo;
Song, Ki Byung;
Jeong, Jae Ho;
Hyung, Jaewon;
Park, Do Hyun;
Song, Tae Jun;
Seo, Dong Wan;
Lee, Sung Koo;
Kim, Myung-Hwan;
Lee, Seung Soo;
Kim, Jin Hee;
Jin, Hyung-seung;
Park, Jin-hong;
Hwang, Dae Wook;
Lee, Jae Hoon;
Lee, Woohyung;
Chang, Heung-Moon;
Kim, Kyu-pyo;
Ryoo, Baek-Yeol

Publication type:

journal article

Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma.

Published in:

2020

By:

Corrie, P. G.;
Qian, W.;
Basu, B.;
Valle, J. W.;
Falk, S.;
lwuji, C.;
Wasan, H.;
Palmer, D.;
Scott-Brown, M.;
Wadsley, J.;
Arif, S.;
Bridgewater, J.;
Propper, D.;
Gillmore, R.;
Gopinathan, A.;
Skells, R.;
Bundi, P.;
Brais, R.;
Dalchau, K.;
Bax, L.

Publication type:

journal article

TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial.

Published in:

2020

By:

Palmer, Daniel H.;
Valle, Juan W.;
Ting Ma, Yuk;
Faluyi, Olusola;
Neoptolemos, John P.;
Jensen Gjertsen, Trine;
Iversen, Berit;
Amund Eriksen, Jon;
Møller, Anne-Sophie;
Aksnes, Anne-Kirsti;
Miller, Robert;
Dueland, Svein;
Ma, Yuk Ting

Publication type:

journal article

Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer: an open-label, single arm, phase 2 trial.

Published in:

2020

By:

Belkouz, Ali;
de Vos-Geelen, Judith;
Mathôt, Ron A. A.;
Eskens, Ferry A. L. M.;
van Gulik, Thomas M.;
van Oijen, Martijn G. H.;
Punt, Cornelis J. A.;
Wilmink, Johanna W.;
Klümpen, Heinz-Josef

Publication type:

journal article

Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma.

Published in:

2020

By:

De Jesus-Acosta, Ana;
Sugar, Elizabeth A.;
O'Dwyer, Peter J.;
Ramanathan, Ramesh K.;
Von Hoff, Daniel D.;
Rasheed, Zeshaan;
Zheng, Lei;
Begum, Asma;
Anders, Robert;
Maitra, Anirban;
McAllister, Florencia;
Rajeshkumar, N. V.;
Yabuuchi, Shinichi;
de Wilde, Roeland F.;
Batukbhai, Bhavina;
Sahin, Ismet;
Laheru, Daniel A.

Publication type:

journal article

Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation.

Published in:

2020

By:

Wattenberg, Max M.;
Asch, Daniella;
Yu, Shun;
O'Dwyer, Peter J.;
Domchek, Susan M.;
Nathanson, Katherine L.;
Rosen, Mark A.;
Beatty, Gregory L.;
Siegelman, Evan S.;
Reiss, Kim A.

Publication type:

journal article

Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials.

Published in:

2018

By:

Cremolini, Chiara;
Milione, Massimo;
Marmorino, Federica;
Morano, Federica;
Zucchelli, Gemma;
Mennitto, Alessia;
Prisciandaro, Michele;
Lonardi, Sara;
Pellegrinelli, Alessio;
Rossini, Daniele;
Bergamo, Francesca;
Aprile, Giuseppe;
Urbani, Lucio;
Morelli, Luca;
Schirripa, Marta;
Cardellino, Giovanni Gerardo;
Fassan, Matteo;
Fontanini, Gabriella;
de Braud, Filippo;
Mazzaferro, Vincenzo

Publication type:

journal article

Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer.

Published in:

2018

By:

Elander, N. O.;
Aughton, K.;
Ghaneh, P.;
Neoptolemos, J. P.;
Palmer, D. H.;
Cox, T. F.;
Campbell, F.;
Costello, E.;
Halloran, C. M.;
Mackey, J. R.;
Scarfe, A. G;
Valle, J. W.;
McDonald, A. C.;
Carter, R.;
Tebbutt, N. C.;
Goldstein, D.;
Shannon, J.;
Dervenis, C.;
Glimelius, B.;
Deakin, M.

Publication type:

journal article

Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer.

Published in:

2018

By:

Kim, R D;
Alberts, S R;
Peña, C;
Genvresse, I;
Ajavon-Hartmann, A;
Xia, C;
Kelly, A;
Grilley-Olson, J E;
Peña, C

Publication type:

journal article

Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study.

Published in:

2018

By:

Salimon, Maëva;
Prieux-Klotz, Caroline;
Tougeron, David;
Hautefeuille, Vincent;
Caulet, Morgane;
Gournay, Jérôme;
Matysiak-Budnik, Tamara;
Bennouna, Jaafar;
Tiako Meyo, Manuela;
Lecomte, Thierry;
Zaanan, Aziz;
Touchefeu, Yann;
Salimon, Maëva;
Gournay, Jérôme

Publication type:

journal article

Efficacy and safety of gemcitabine plus S-1 in pancreatic cancer: a pooled analysis of individual patient data.

Published in:

2017

By:

Hamada, Chikuma;
Okusaka, Takuji;
Ikari, Takaaki;
Isayama, Hiroyuki;
Furuse, Junji;
Ishii, Hiroshi;
Nakai, Yousuke;
Imai, Shogo;
Okamura, Shota

Publication type:

journal article

Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer.

Published in:

2017

By:

Haas, Michael;
Ormanns, Steffen;
Baechmann, Sibylle;
Remold, Anna;
Kruger, Stephan;
Westphalen, Christoph B;
Siveke, Jens T;
Wenzel, Patrick;
Schlitter, Anna Melissa;
Esposito, Irene;
Quietzsch, Detlef;
Clemens, Michael R;
Kettner, Erika;
Laubender, Ruediger P;
Jung, Andreas;
Kirchner, Thomas;
Boeck, Stefan;
Heinemann, Volker

Publication type:

journal article

Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer.

Published in:

2017

By:

Hurt, C N;
Falk, S;
Crosby, T;
McDonald, A;
Ray, R;
Joseph, G;
Staffurth, J;
Abrams, R A;
Griffiths, G;
Maughan, T;
Mukherjee, S

Publication type:

journal article

Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer.

Published in:

2016

By:

Rajeshkumar, N V;
Yabuuchi, Shinichi;
Pai, Shweta G;
Tong, Zeen;
Hou, Shihe;
Bateman, Scott;
Pierce, Daniel W;
Heise, Carla;
Von Hoff, Daniel D;
Maitra, Anirban;
Hidalgo, Manuel

Publication type:

journal article

Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma.

Published in:

2016

By:

Reni, Michele;
Balzano, Gianpaolo;
Zanon, Silvia;
Passoni, Paolo;
Nicoletti, Roberto;
Arcidiacono, Paolo Giorgio;
Pepe, Gino;
Doglioni, Claudio;
Fugazza, Clara;
Ceraulo, Domenica;
Falconi, Massimo;
Gianni, Luca

Publication type:

journal article

Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy.

Published in:

2016

By:

Moriwaki, Toshikazu;
Yamamoto, Yoshiyuki;
Gosho, Masahiko;
Kobayashi, Mariko;
Sugaya, Akinori;
Yamada, Takeshi;
Endo, Shinji;
Hyodo, Ichinosuke

Publication type:

journal article

Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer.

Published in:

2016

By:

Pothula, Srinivasa P;
Xu, Zhihong;
Goldstein, David;
Biankin, Andrew V;
Pirola, Romano C;
Wilson, Jeremy S;
Apte, Minoti V

Publication type:

journal article

Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer.

Published in:

2015

By:

Miyamae, Mahito;
Komatsu, Shuhei;
Ichikawa, Daisuke;
Kawaguchi, Tsutomu;
Hirajima, Shoji;
Okajima, Wataru;
Ohashi, Takuma;
Imamura, Taisuke;
Konishi, Hirotaka;
Shiozaki, Atsushi;
Morimura, Ryo;
Ikoma, Hisashi;
Ochiai, Toshiya;
Okamoto, Kazuma;
Taniguchi, Hiroki;
Otsuji, Eigo

Publication type:

journal article

Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort.

Published in:

2015

By:

Portal, Alix;
Pernot, Simon;
Tougeron, David;
Arbaud, Claire;
Bidault, Anne Thirot;
de la Fouchardière, Christelle;
Hammel, Pascal;
Lecomte, Thierry;
Dréanic, Johann;
Coriat, Romain;
Bachet, Jean-Baptiste;
Dubreuil, Olivier;
Marthey, Lysiane;
Dahan, Laetitia;
Tchoundjeu, Belinda;
Locher, Christophe;
Lepère, Céline;
Bonnetain, Franck;
Taieb, Julien;
de la Fouchardière, Christelle

Publication type:

journal article

Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancers.

Published in:

British Journal of Cancer, 2013, v. 108, n. 8, p. 1750, doi. 10.1038/bjc.2013.142

By:

Piazzi, G;
Selgrad, M;
Garcia, M;
Ceccarelli, C;
Fini, L;
Bianchi, P;
Laghi, L;
D'Angelo, L;
Paterini, P;
Malfertheiner, P;
Chieco, P;
Boland, C R;
Bazzoli, F;
Ricciardiello, L

Publication type:

Article

Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2′-deoxycytidine on ovarian cancer.

Published in:

British Journal of Cancer, 2013, v. 108, n. 3, p. 579, doi. 10.1038/bjc.2013.10

By:

Meng, F;
Sun, G;
Zhong, M;
Yu, Y;
Brewer, M A

Publication type:

Article

Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours.

Published in:

British Journal of Cancer, 2012, v. 107, n. 8, p. 1268, doi. 10.1038/bjc.2012.407

By:

Martin, L. P.;
Kozloff, M. F.;
Herbst, R. S.;
Samuel, T. A.;
Kim, S.;
Rosbrook, B.;
Tortorici, M.;
Chen, Y.;
Tarazi, J.;
Olszanski, A. J.;
Rado, T.;
Starr, A.;
Cohen, R. B.

Publication type:

Article

A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study).

Published in:

2011

By:

LeCaer, H;
Barlesi, F;
Corre, R;
Jullian, H;
Bota, S;
Falchero, L;
Vergnenegre, A;
Dujon, C;
Delhoume, J Y;
Chouaid, C;
GFPC 0504 Team

Publication type:

journal article